Nomograms to Predict the Density of Tumor-Infiltrating Lymphocytes in Patients With High-Grade Serous Ovarian Cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nomograms to Predict the Density of Tumor-Infiltrating Lymphocytes in Patients With High-Grade Serous Ovarian Cancer
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-02-25
DOI
10.3389/fonc.2021.590414
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Prognostic Implications of Tumor Infiltrating Lymphocytes in Colorectal Cancer: A Systematic Review and Meta-Analysis
- (2020) Gregory E. Idos et al. Scientific Reports
- Association of chromosome 7 aneuploidy measured by fluorescence in situ hybridization assay with muscular invasion in bladder cancer
- (2020) Xiayao Diao et al. Cancer Communications
- Overview of multiplex immunohistochemistry/immunofluorescence techniques in the era of cancer immunotherapy
- (2020) Wei Chang Colin Tan et al. Cancer Communications
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Prognostic value of tumor-infiltrating lymphocytes in melanoma: a systematic review and meta-analysis
- (2019) Qiaofen Fu et al. OncoImmunology
- Multi-omics analysis reveals neoantigen-independent immune cell infiltration in copy-number driven cancers
- (2018) Daniel J. McGrail et al. Nature Communications
- Patient inflammatory status and CD4+/CD8+ intraepithelial tumor lymphocyte infiltration are predictors of outcomes in high-grade serous ovarian cancer
- (2018) Mauricio P. Pinto et al. GYNECOLOGIC ONCOLOGY
- A nomogram to predict pathologic complete response (pCR) and the value of tumor-infiltrating lymphocytes (TILs) for prediction of response to neoadjuvant chemotherapy (NAC) in breast cancer patients
- (2018) Hye Won Hwang et al. BREAST CANCER RESEARCH AND TREATMENT
- Nomogram Based on Systemic Immune-Inflammation Index to Predict Overall Survival in Gastric Cancer Patients
- (2018) Hongtai Shi et al. DISEASE MARKERS
- Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti–PD-L1)
- (2018) Marcin Kowanetz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neoadjuvant chemotherapy for advanced-stage ovarian cancer: Are the ASCO and SGO recommendations warranted?
- (2017) Steven Narod et al. GYNECOLOGIC ONCOLOGY
- Impact of neoadjuvant chemotherapy on the immune microenvironment in advanced epithelial ovarian cancer: Prognostic and therapeutic implications
- (2017) Aya S. Khairallah et al. INTERNATIONAL JOURNAL OF CANCER
- DNA methylation–based immune response signature improves patient diagnosis in multiple cancers
- (2017) Jana Jeschke et al. JOURNAL OF CLINICAL INVESTIGATION
- LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells
- (2016) Almut Brand et al. Cell Metabolism
- Neoadjuvant Chemotherapy of Ovarian Cancer Results in Three Patterns of Tumor-Infiltrating Lymphocyte Response with Distinct Implications for Immunotherapy
- (2016) Charlotte S. Lo et al. CLINICAL CANCER RESEARCH
- Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline
- (2016) Alexi A. Wright et al. GYNECOLOGIC ONCOLOGY
- Nomograms for Predicting the Prognostic Value of Pre-Therapeutic CA15-3 and CEA Serum Levels in TNBC Patients
- (2016) Danian Dai et al. PLoS One
- The Lymphocyte-Monocyte Ratio Predicts Patient Survival and Aggressiveness of Ovarian Cancer
- (2016) Wan Kyu Eo et al. Journal of Cancer
- Tumor infiltrating lymphocytes in ovarian cancer
- (2015) Phillip P Santoiemma et al. CANCER BIOLOGY & THERAPY
- Nomogram for predicting incomplete cytoreduction in advanced ovarian cancer patients
- (2015) Seung-Hyuk Shim et al. GYNECOLOGIC ONCOLOGY
- FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication
- (2015) Jaime Prat Journal of Gynecologic Oncology
- Nomograms in oncology: more than meets the eye
- (2015) Vinod P Balachandran et al. LANCET ONCOLOGY
- The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
- (2014) R. Salgado et al. ANNALS OF ONCOLOGY
- New insights into cancer immunoediting and its three component phases—elimination, equilibrium and escape
- (2014) Deepak Mittal et al. CURRENT OPINION IN IMMUNOLOGY
- Development and internal validation of a prognostic model for survival after debulking surgery for epithelial ovarian cancer
- (2014) M.J. Rutten et al. GYNECOLOGIC ONCOLOGY
- Prognostic significance and predictors of the neutrophil-to-lymphocyte ratio in ovarian cancer
- (2014) Kristina A. Williams et al. GYNECOLOGIC ONCOLOGY
- Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer
- (2014) Gottfried E. Konecny et al. JNCI-Journal of the National Cancer Institute
- The Value of Tumor Infiltrating Lymphocytes (TILs) for Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer: A Systematic Review and Meta-Analysis
- (2014) Yan Mao et al. PLoS One
- Harnessing the immune system to provide long-term survival in patients with melanoma and other solid tumors
- (2014) Alexander Eggermont et al. OncoImmunology
- The role of tumour-associated MUC1 in epithelial ovarian cancer metastasis and progression
- (2013) Junli Deng et al. CANCER AND METASTASIS REVIEWS
- Clear cell histology as a poor prognostic factor for advanced epithelial ovarian cancer: a single institutional case series through central pathologic review
- (2013) Morikazu Miyamoto et al. Journal of Gynecologic Oncology
- Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours
- (2013) Jérôme Galon et al. JOURNAL OF PATHOLOGY
- Tumor-infiltrating Lymphocytes, Tumor Characteristics, and Recurrence in Patients With Early Breast Cancer
- (2012) Seung Tae Kim et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Inflammation and ovarian cancer
- (2012) Antonio Macciò et al. CYTOKINE
- Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer
- (2012) Kelly L. Bolton JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Factors associated with the age of natural menopause and menopausal symptoms in Chinese women
- (2012) Lin Li et al. MATURITAS
- Paraneoplastic Thrombocytosis in Ovarian Cancer
- (2012) Rebecca L. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunobiology of human mucin 1 in a preclinical ovarian tumor model
- (2012) R A Budiu et al. ONCOGENE
- Increased pretreatment levels of serum LDH and ALP as poor prognostic factors for nasopharyngeal carcinoma
- (2012) Guo Li et al. Chinese Journal of Cancer
- Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer
- (2011) Viren Asher et al. Clinical & Translational Oncology
- Prognostic significance of tumor-infiltrating T cells in ovarian cancer: A meta-analysis
- (2011) Wei-Ting Hwang et al. GYNECOLOGIC ONCOLOGY
- Exploitation of the propulsive force of chemotherapy for improving the response to cancer immunotherapy
- (2011) Enrico Proietti et al. Molecular Oncology
- The immunologic aspects in advanced ovarian cancer patients treated with paclitaxel and carboplatin chemotherapy
- (2009) Xia Wu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Interleukin-6 and leptin as markers of energy metabolicchanges in advanced ovarian cancer patients
- (2008) Antonio Macciò et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma
- (2007) Markéta Tomšová et al. GYNECOLOGIC ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now